Rahul Mannan

20PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityHaematological tumoursSeparation technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 07, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Aug 25, 2025
Cellular cartography reveals mouse prostate organization and determinants of castration resistance.

Hanbyul Cho, Yuping Zhang, Jean C Tien

|Jun 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Sanjana Eyunni, Rahul Mannan, Yuping Zhang

|Jun 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.

Jean Ching-Yi Tien, Yali Zhai, Rong Wu

Pageof 4